Drug Shortage Report for APO-ALENDRONATE
Report ID | 162080 |
Drug Identification Number | 02248730 |
Brand name | APO-ALENDRONATE |
Common or Proper name | ALENDRONATE |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | ALENDRONIC ACID |
Strength(s) | 70MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 BTL |
ATC code | M05BA |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-06-02 |
Estimated end date | 2022-08-12 |
Actual end date | 2022-08-10 |
Shortage status | Resolved |
Updated date | 2022-08-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-06-06 | English | Compare |
v2 | 2022-06-06 | French | Compare |
v3 | 2022-06-30 | English | Compare |
v4 | 2022-06-30 | French | Compare |
v5 | 2022-07-28 | English | Compare |
v6 | 2022-07-28 | French | Compare |
v7 | 2022-08-11 | English | Compare |
v8 | 2022-08-11 | French | Compare |
Showing 1 to 8 of 8